Individuals with PHP1A are at increased risk of decreased insulin sensitivity, hyperglycemia, and diabetes, and understanding the underpinnings of their obesity is critical to help prevent and manage these metabolic complications [19]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.